Metaxa Hospital THromboprophylaxis Program in Oncological & Surgical Patients (MeTHOS)

Metaxa Hospital

Status: Unknown

Conditions: Thrombosis; Solid Cancer

Treatments: Drug: Low Molecular Weight Heparin

Study type: Observational

Funder types: Other

Identifiers

NCT04248348

2394-05/02/2019

Details and patient eligibility

About

During MeTHOS study will be collected Real World Data the clinical practice regarding Thromboprophylaxis in high thrombotic risk solid tumors patients undergoing surgical and /or chemotherapeutical treatment, for one year following the protocol initiation date.

Specifically focus will be on the following:

• Number of thrombotic events
• Anti-thrombotic management dosage & duration
• Any bleedings related to anticoagulation
• Patients' adherence and compliance

Enrollment: 600 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

1. Patients who were diagnosed with histological confirmed high thrombotic risk cancers (GI, thoracic, gynecologic and genitourinary) undergoing surgery
2. Age ≥ 18 years
3. Eastern Cooperative Oncology Group (ECOG) performance status 0-2
4. Life expectancy >6 months
5. Signed informed consent

Exclusion Criteria

1. Patients who were not diagnosed with histological confirmed high thrombotic risk cancers (GI, thoracic, gynecologic and genitourinary) undergoing surgery
2. Age < 18 years
3. ECOG performance status >2
4. Life expectancy <6 months
5. Not signed informed consent

Trial design